Compare PCTY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCTY | MEDP |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 13.0B |
| IPO Year | 2014 | 2016 |
| Metric | PCTY | MEDP |
|---|---|---|
| Price | $104.47 | $528.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 12 |
| Target Price | $176.59 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 708.8K | 281.0K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.74 | ★ 20.98 |
| EPS | 3.81 | ★ 4.28 |
| Revenue | ★ $1,595,221,000.00 | N/A |
| Revenue This Year | $11.52 | $13.19 |
| Revenue Next Year | $7.98 | $7.75 |
| P/E Ratio | ★ $27.75 | $124.84 |
| Revenue Growth | ★ 13.74 | N/A |
| 52 Week Low | $92.99 | $306.70 |
| 52 Week High | $197.78 | $628.92 |
| Indicator | PCTY | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 76.22 |
| Support Level | $100.13 | $530.96 |
| Resistance Level | $106.19 | $539.06 |
| Average True Range (ATR) | 3.98 | 17.80 |
| MACD | -0.17 | 7.51 |
| Stochastic Oscillator | 41.18 | 91.28 |
Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2025, Paylocity has nearly 42,000 customers.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.